Briefing Stayed In 1 Patent Case As Rehearing Bid Considered In Another
WASHINGTON, D.C. — A dispute between an unsuccessful petitioner for inter partes review (IPR) and a university over a patent covering the production of nicotinamide riboside (NR) and compositions containing NR...To view the full article, register now.
Already a subscriber? Click here to view full article